^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Invasive breast cancer: HER2 negative....Useful in certain circumstances:...Carboplatin + paclitaxel or albumin-bound paclitaxel
Evidence Level:
Sensitive: C2 – Inclusion Criteria
New
Title:

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

Excerpt:
...HER2 negative disease 4....
Trial ID:
Evidence Level:
Sensitive: C2 – Inclusion Criteria
New
Title:

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer

Excerpt:
......
Trial ID:
More C2 evidence